GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (LSE:INDV) » Definitions » Total Equity

Indivior (LSE:INDV) Total Equity : £7.9 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Indivior Total Equity?

Indivior's total equity for the quarter that ended in Mar. 2024 was £7.9 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Indivior Total Equity Historical Data

The historical data trend for Indivior's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior Total Equity Chart

Indivior Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 159.47 61.01 152.66 41.87 1,050.70

Indivior Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.33 92.66 -19.39 1,050.70 7.87

Indivior Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Indivior's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=1543.66-1543.66
=0.0

Indivior's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=1143.511-1135.641
=7.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indivior Total Equity Related Terms

Thank you for viewing the detailed overview of Indivior's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Indivior (LSE:INDV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (LSE:INDV) » Definitions » Total Equity
Comparable Companies
LSE:HCM LSE:BMK LSE:APH LSE:HIK LSE:ANCR LSE:EAH LSE:AGY LSE:CEL LSE:STX LSE:VLG ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
INDV:USA INDVl:UK 2IVB:Germany
Address
234 Bath Road, Slough, Berkshire, GBR, SL1 4EE
Website
http://www.indivior.com
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.